Pricing Log in Create free account

ProKidney Corp. (PROK) vs PureTech Health PLC Sponsored ADR (PRTCY)

ProKidney Corp. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. ProKidney Corp. and PureTech Health PLC Sponsored ADR are of similar size ($439.9M and $424.0M). PureTech Health PLC Sponsored ADR has the higher net margin (−199.4% vs −10,288.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PureTech Health PLC Sponsored ADR leads on 7 and ProKidney Corp. on 5.

Valuation

Metric PROK PRTCY Biotechnology median
P/E n/m n/m 8.50
P/S 303.33 n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.81 0.64
EV/Sales 81.78 (9.10) 9.21
Earnings yield (41.35%) (1.48%) (33.15%)
Free cash flow yield (57.04%) 0.00% (25.50%)

Profitability

Metric PROK PRTCY Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (21,664.55%) 0.00% 0.00%
Net margin (10,288.39%) (199.36%) 0.00%
Free cash flow margin (17,300.61%) 0.00% 0.00%
Return on equity 8.92% 0.00% (56.36%)
Return on assets (27.10%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PROK PRTCY Biotechnology median
Revenue growth (TTM) — 28.48% 6.02%
EPS growth (last fiscal year) 16.13% (2,277.05%) 30.26%
Revenue growth, 5-year CAGR — (16.92%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PROK PRTCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.36 6.59 4.72
Net debt to EBITDA 1.70 3.03 0.96

Dividend

Metric PROK PRTCY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PROK PRTCY Biotechnology median
Market cap 439.88m 424.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack